$472 Million is the total value of Euclidean Capital LLC's 10 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PMVP | New | PMV PHARMACEUTICALS INC | $257,076,000 | – | 4,179,416 | +100.0% | 54.42% | – |
| NGM | New | NGM BIOPHARMACEUTICALS INC | $63,133,000 | – | 2,083,602 | +100.0% | 13.36% | – |
| ORIC | New | ORIC PHARMACEUTICALS INC | $47,405,000 | – | 1,400,435 | +100.0% | 10.04% | – |
| DNLI | New | DENALI THERAPEUTICS INC | $27,117,000 | – | 323,749 | +100.0% | 5.74% | – |
| FHTX | New | FOGHORN THERAPEUTICS INC | $25,566,000 | – | 1,261,261 | +100.0% | 5.41% | – |
| CNST | New | CONSTELLATION PHARMCETICLS I | $15,965,000 | – | 554,325 | +100.0% | 3.38% | – |
| ALEC | New | ALECTOR INC | $14,841,000 | – | 980,894 | +100.0% | 3.14% | – |
| RAPT | New | RAPT THERAPEUTICS INC | $14,532,000 | – | 735,801 | +100.0% | 3.08% | – |
| RVMD | New | REVOLUTION MEDICINES INC | $3,699,000 | – | 93,436 | +100.0% | 0.78% | – |
| FFBC | New | FIRST FINL BANCORP OH | $3,043,000 | – | 173,576 | +100.0% | 0.64% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PMV PHARMACEUTICALS INC | 12 | Q3 2023 | 54.4% |
| FOGHORN THERAPEUTICS INC | 12 | Q3 2023 | 16.4% |
| NGM BIOPHARMACEUTICALS INC | 12 | Q3 2023 | 14.5% |
| ALECTOR INC | 12 | Q3 2023 | 11.5% |
| RAPT THERAPEUTICS INC | 12 | Q3 2023 | 9.7% |
| ORIC PHARMACEUTICALS INC | 12 | Q3 2023 | 10.0% |
| TENAYA THERAPEUTICS INC | 9 | Q3 2023 | 9.9% |
| FIRST FINL BANCORP OH | 9 | Q4 2022 | 3.9% |
| SURROZEN INC | 9 | Q3 2023 | 2.9% |
| 23ANDME HOLDING CO | 7 | Q3 2023 | 27.2% |
View Euclidean Capital LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. | February 14, 2022 | 2,336,909 | 5.1% |
View Euclidean Capital LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2023-12-01 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Euclidean Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.